Home › COVID-19 and Coronavirus Infections › California › San Francisco
COVID-19 and Coronavirus Infections clinical trials in San Francisco, CA
3 studies for COVID-19 and Coronavirus Infections are looking for participants at sites in and around San Francisco (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
RecruitingPhase 3
- University of California San Francisco, San Francisco
A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses
RecruitingPhase 1/2Healthy volunteers welcome
- UCSF Community and Clinical Research Center, San Francisco
Long-term Impact of Infection With Novel Coronavirus (COVID-19)
RecruitingObservational study
- Zuckerberg San Francisco General Hospital (ZSFG), San Francisco
COVID-19 and Coronavirus Infections trials in other cities
- Washington, DC7 studies
- Houston, TX5 studies
- Durham, NC5 studies
- Dallas, TX5 studies
- Boston, MA5 studies
- Atlanta, GA5 studies
- Los Angeles, CA4 studies
- New York City, NY4 studies
- Hialeah, FL4 studies
- Cincinnati, OH3 studies
- Pittsburgh, PA3 studies
- Chicago, IL3 studies
Other studies in San Francisco
- Prostate Cancer45 studies
- Breast Cancer43 studies
- Non-Small Cell Lung Cancer36 studies
- Cancer (all types)35 studies
- Heart Failure29 studies
- Metastatic Cancer28 studies
- Lung Cancer22 studies
- Melanoma22 studies
- Pancreatic Cancer20 studies
- Ovarian Cancer19 studies
- Colorectal Cancer18 studies
- Cardiovascular Disease18 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.